Oligodendrocyte Development and Regenerative Therapeutics in Multiple Sclerosis
Nadjet Gacem1, Brahim Nait-Oumesmar1
1Institut du Cerveau-Paris Brain Institute-ICM, Inserm, CNRS, AP-HP, Hôpital de la Pitié Salpêtrière, Sorbonne Université, 75013 Paris, France.
Life (Basel, Switzerland)
|April 30, 2021
Summary
Oligodendrocytes (OLs) are crucial for central nervous system (CNS) myelination. This review covers OL differentiation, myelination, and remyelination, focusing on multiple sclerosis (MS) and potential treatments.
Area of Science:
- Neuroscience
- Cell Biology
- Developmental Biology
Background:
- Myelination by oligodendrocytes (OLs) is vital for central nervous system (CNS) development and function.
- Oligodendrocyte progenitor cells (OPCs) undergo significant changes to become myelinating OLs, regulated by gene expression and signaling pathways.
- Dysfunctional myelination is linked to neurodegenerative diseases, notably multiple sclerosis (MS).
Purpose of the Study:
- To review current knowledge on oligodendrocyte differentiation, myelination, and remyelination.
- To highlight the role of oligodendrocytes in CNS health and disease.
- To discuss multiple sclerosis (MS) as a key pathological condition involving demyelination.
Main Methods:
- Literature review of oligodendrocyte biology.
- Focus on gene expression and signaling pathways in OL differentiation.
- Analysis of pathological mechanisms in multiple sclerosis (MS).
Main Results:
- Oligodendrocyte differentiation involves specific molecular and morphological changes.
- Aberrant myelination or oligodendrocyte loss contributes to neurodegenerative conditions like MS.
- Current MS treatments primarily address immune aspects, with limited impact on remyelination.
Conclusions:
- Understanding oligodendrocyte differentiation is key to addressing CNS disorders.
- Targeting remyelination presents a promising therapeutic avenue for MS.
- Further research into pharmacological compounds for remyelination is ongoing and crucial for MS treatment.
Related Concept Videos
01:15Neurogenesis and Regeneration of Nervous Tissue
1.2K
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
1.2K
01:25Nervous Tissue: Myelin
4.2K
The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
4.2K
01:22iPS Cell Differentiation
2.9K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.9K